The S&P/ASX 200 Index (ASX: XJO) has fallen further this week as investor sentiment continues to deteriorate.

Ongoing conflict between the US and Iran is driving fresh concerns about restricted oil supply and inflation, and the renewed fears about further interest rate hikes are spooking investors.

Let’s find out how the shift in sentiment is affecting major ASX 200 shares like Domino’s Pizza Enterprises Ltd (ASX: DMP), Telix Pharmaceuticals Ltd (ASX: TLX), and Wesfarmers Ltd (ASX: WES), and what brokers tip next.

Buy Telix Pharmaceuticals shares

Telix shares have rocketed over 10% higher in Tuesday afternoon trade to $17.99 apiece. Today’s increase means the shares are now up 58% year to date.

Today’s increase comes on the back of yesterday’s news that its brain cancer imaging drug, Pixclara, has received approval from the US FDA. This makes it the first FET-PET imaging drug cleared for use in glioma and expands Telix’s precision medicine portfolio.

Telix says Pixclara is already the subject of a Phase 3 trial for diagnosis in additional brain conditions, with potential expansion to brain metastases. 

The company said it plans to target market leadership in both imaging and treatment for several high-need cancers.

Telix’s broader pipeline includes late-stage assets in prostate, kidney, and glioblastoma cancers, with a focus on bringing further precision medicine products to both existing and new markets worldwide.

Investors were clearly thrilled with the news, and many are rushing to snap up the shares.

Analysts are very bullish on the outlook for the stock, too. Market Index data shows the majority of brokers have a buy rating on the shares, and even after today’s share price spike, the $24.68 average target price implies there is potential for about 37% upside ahead.

Hold Domino’s Pizza shares

Domino’s Pizza shares have climbed higher on Tuesday afternoon, up around 1% to $19.14 a piece at the time of writing. The shares are still down 12% year to date.

It’s been a volatile month for the pizza operator. Its share price fell around 6% after the food operator announced its FY26 results, including a 11.2% decrease in revenue, and a statutory NPAT loss of $134.2 million. It also announced $255.7 million in non-cash write-downs and impairments.

Domino’s underlying NPAT was up 4% for the 12-month period, and in line with guidance, but EBITDA fell 6.1%. The company also cut its total FY26 dividend by 25.3% to 57.5 cents.

Going forward, Domino’s said it is planning to return to profitable growth in FY27 after a period of resetting its store network and business model. 

But it looks like the experts are on the fence about whether this growth can come to fruition. Market Index data shows the majority of brokers have a hold rating on the ASX shares. The $20.10 average target price implies an upside of around 5% at the time of writing.

Sell Wesfarmers shares

Wesfarmers shares are in the red at the time of writing, down around 0.5% to $72.42 each. The shares have crashed by around 22% since late July and are now down 11% for the year to date.

The shares were pushed lower in August amid broad pressure on consumer and retail stocks, as well as concerns about inflation and interest rate increases.

The sell-off also picked up pace after the conglomerate posted its FY26 results in late August.

The company reported a 3.4% increase in revenue to $47.3 million and a 7.3% increase in EBIT. But statutory NPAT fell 1.8% to $2.8 million, including significant items, or was up 8.3% excluding them. 

Going forward, Wesfarmers said it expects higher capital expenditure in FY27, of $1.3 billion to $1.5 billion. 

But investors were spooked, potentially because, although the result was robust, it raises questions about how the business can continue to grow in a weakening market.

Brokers are concerned, too. Market Index data shows the majority now have a strong sell rating on Wesfarmers shares. After the latest price crash, the $77 average target price implies around a 6% upside at the time of writing.

The post Buy, hold, sell: Domino’s Pizza, Telix Pharmaceuticals, Westfarmers shares appeared first on The Motley Fool Australia.

More reading

• How much is needed in superannuation to target a $6,500 monthly passive income?
• Here are the top 10 ASX 200 shares today
• Why are Telix Pharmaceuticals shares charging higher today?
• Telix Pharmaceuticals shares: FDA approves Pixclara brain cancer drug
• By September 2027, Wesfarmers shares could turn $10,000 into…

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Domino’s Pizza Enterprises, Telix Pharmaceuticals, and Wesfarmers. The Motley Fool Australia has recommended Domino’s Pizza Enterprises, Telix Pharmaceuticals, and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

SpaceX has been one of the highest-profile listings of 2026.

But excitement and a good entry price are not always the same thing.

Space Exploration Technologies Corp (NASDAQ: SPCX) shares closed at US$148.15 on Monday.

That’s above the US$135 IPO price, although the stock has already been on a wild ride since listing in June.

It briefly traded as high as US$225.64 just days after its debut.

Investors who chased the early surge are already sitting on a sizeable loss.

And while the 34% pullback makes SpaceX look cheaper, that doesn’t necessarily mean it’s good value.

Yes, I would love to own SpaceX shares at some point.

I just wouldn’t buy them around current levels.

Why I want to own SpaceX

There is a lot I like about the business.

SpaceX has built a position that would be extremely difficult for another company to copy.

Its launch business is already enormous, and Starlink continues to add customers.

Starship could also dramatically reduce the cost of putting satellites and other payloads into orbit if the program works as planned.

The growth numbers are pretty impressive, too.

Second-quarter revenue jumped 92% to US$7.8 billion, while adjusted EBITDA rose 191% to US$3.5 billion.

Starlink now has around 12 million subscribers, and SpaceX is also spending heavily on AI infrastructure alongside its space and connectivity businesses.

Evidently, this will give the company several ways to grow over the next decade.

So what’s stopping me?

The price.

At around US$148 per share, SpaceX has a market cap at roughly US$2 trillion.

That’s a huge valuation, especially for a company that still reported a US$541 million net loss in the second quarter.

It’s spending heavily as well.

Capital expenditure reached US$18.4 billion during the quarter, with US$15.8 billion going towards AI infrastructure.

Of course, SpaceX could eventually grow into that valuation.

Interestingly, Wall Street thinks there’s more upside, with the average analyst price target sitting around US$227.

But at the current price, I think investors are already paying for a lot of future growth.

Where would I buy?

For me, things would get much more interesting below US$90.

That would mean a fall of roughly 39% from yesterday’s closing price and put the shares well below their US$135 IPO price.

Would SpaceX suddenly be cheap at US$90? Probably not.

But I’d be much more comfortable starting a position around that level.

At that price, I’d have a lot more room for things to go wrong.

SpaceX is a company I genuinely want in my portfolio.

I’m just happy to miss some upside if the alternative is paying too much.

The post SpaceX shares are flying. Here’s the price I’d wait for appeared first on The Motley Fool Australia.

More reading

• Forget CBA shares! Buy these ASX dividend shares instead for passive income
• Buy, hold, sell: Domino’s Pizza, Telix Pharmaceuticals, Westfarmers shares
• WiseTech Global vs Xero: Which fallen ASX tech share is the better buy today?
• 2 ASX 200 shares tipped by brokers to return 73% and 83%
• This ASX ETF could help protect your portfolio

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

WiseTech Global vs Xero shares: Which fallen tech giant bounces back first?

If you’re juggling between WiseTech Global Ltd (ASX: WTC) and Xero Ltd (ASX: XRO) shares, you’re not alone. These two tech heavyweights have led Australia and New Zealand’s software scene, but both have seen major declines from recent market highs. Let’s break down their fundamentals and find out which might be the buy after the fall.

The case for WiseTech Global

WiseTech Global builds logistics software that powers the world’s largest freight companies. Its flagship CargoWise One platform is used by top 25 global freight forwarders—think names like DHL and Toll. Founded in 1994 and based in Sydney, WiseTech has expanded its reach worldwide, helping streamline complex supply chains across every continent.

What stands out for WiseTech is its proven global customer base, consistent profitability, and a small—but steadily rising—fully franked dividend. As of the latest data, WiseTech trades on a price-to-earnings (P/E) ratio of 44.37 with a market cap of $10.91 billion. Its dividend yield is just 0.67%, but those payouts have grown impressively over the years and are 100% franked. Year to date, the share price has dropped a hefty 51.93%. That’s a big pullback for any investor.

The case for Xero

New Zealand’s Xero is a cloud-based accounting software business that’s become a leader for small to medium enterprises. Running a classic SaaS (Software as a Service) model, Xero offers monthly subscriptions at varied price points, making life easier for businesses needing streamlined accounts. Founded in 2006, it’s quickly carved a global name in cloud accounting.

Xero is actually the larger company by market capitalisation ($11.54 billion) but lacks WiseTech’s dividend appeal—payouts are currently zero. The latest P/E ratio stands at 49.87, significantly higher than most traditional businesses, and crucially, Xero posted negative earnings per share (-$0.158), meaning it’s not currently profitable. Franking is not applicable. Still, despite the lack of profits or dividends, Xero’s recurring revenue base is sticky, and its growth aspirations are ambitious. Yet the share price is down 41.19% over the year to date, tracking a major fall from its earlier highs.

Valuation comparison

There’s plenty to weigh up between these two. Here’s a head-to-head of the key numbers:

Metric	WiseTech Global	Xero
Market Cap	$10.91 billion	$11.54 billion
P/E Ratio	44.37	49.87
Earnings per Share	$0.485	-$0.158
Dividend Yield	0.67% (100% franked)	0.00%
Year-to-date Return	-51.93%	-41.19%

Xero commands a slight premium on size and valuation, but WiseTech is more profitable and offers a (modest) dividend. Both have seen huge share price declines, with WiseTech falling further in percentage terms.

Recent share price performance

Neither stock has been immune from the market’s tech re-rate. According to closing prices from 14 September 2026, WiseTech Global finished at $32.44—down from recent highs near $46 in late August, with a year-to-date loss of nearly 52%. Xero, meanwhile, closed at $67.63, having traded above $89 as recently as late August and is now down 41% for the year.

The data shows both stocks have tumbled heavily from recent peaks, but WiseTech’s slump is steeper: from $45.47 on 25 August to $32.44 on 14 September, a loss of about 29% in less than three weeks. Xero’s decline in the same window was from $88.95 to $67.63, about 24%. These are not live prices and only reflect the last reported period.

Which is the better buy?

Both WiseTech and Xero have suffered hard falls from grace, and I reckon this creates opportunity—but also real risk. If I had to pick one, my choice would be WiseTech Global. Here’s why: it’s still generating profits, pays a growing (if small) 100% franked dividend, and offers fundamental exposure to trade and global supply chains that should recover with the economic cycle. Xero’s negative earnings, lack of dividends, and a higher valuation ratio tilt the risk/reward less in its favour for now, despite its sticky SaaS model and global ambitions.

That said, both companies remain high-growth, high-multiple tech stocks that have come back to earth hard. I see WiseTech’s collapse as the harsher overreaction, with the safety net of actual profits and cash returns—even if modest—being enough to give it my nod over Xero right now.

The post WiseTech Global vs Xero: Which fallen ASX tech share is the better buy today? appeared first on The Motley Fool Australia.

More reading

• WiseTech shares have been smashed in 2026. Here’s why I wouldn’t bet against them
• WiseTech shares are down 65%. Have brokers finally spotted a bargain?
• 3 ASX 200 shares I’d buy if I couldn’t sell for 10 years
• Down 63%, I think WiseTech shares could be heading for a huge comeback
• Down 13% in a week: Is the Xero share price finally cheap enough to buy?

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended WiseTech Global and Xero. The Motley Fool Australia has positions in and has recommended WiseTech Global and Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial draft. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.